Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a traditional chinese herb pill help Lung-Heart patients breathe easier?

NCT ID NCT07604805

Recruiting now Disease control Sponsor: Guangdong Provincial People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding Qishen Yiqi Dropping Pills, a Chinese herbal medicine, to standard therapy can improve exercise ability and quality of life in 120 adults with severe pulmonary hypertension. Participants will be randomly assigned to receive either the herbal pills plus standard drugs or standard drugs alone for 52 weeks. The main outcomes are changes in walking distance, symptom scores, and perceived exertion.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Qishen Yiqi Dropping Pills (a Chinese patent medicine made from astragalus, salvia, notoginseng, and dalbergia)
What this could lead to
If it works, this could offer a safe add-on treatment to help people with severe pulmonary hypertension walk farther and feel better day-to-day.
What could go wrong
This is a relatively small, early-stage trial (120 people) testing a supplement to standard care. The herbal product may not provide meaningful extra benefit, and side effects are not yet well understood.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Familial Primary Pulmonary Hypertension idiopathic pulmonary arterial hypertension pulmonary arterial hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IDIOPATHIC PULMONARY HYPERTENSION

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Guangdong Provincial People's Hospital

    RECRUITING

    Guangzhou, Guagdong, 515000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.